Spray Drying

Source: Thermo Fisher Scientific

Overcoming formulation challenges is a key step on the path toward commercialization, and spray drying has emerged as an efficacious solution for enhancing the bioavailability of poorly soluble APls. By partnering with an experienced CDMO, drug sponsors can harness extensive capabilities and expertise in process development, scale-up, and manufacturing of spray dried material for preclinical to commercial needs.

Thermo Fisher Scientific has manufacturing capabilities for amorphous solid dispersions to enhance bioavailability of poorly soluble molecules, applicable to a broad range of APIs. Patheon™ Quadrant 2™ predictive modeling will predict the best technology to enable the enhancement of your molecule’s solubility, and the available API manufacturing capabilities, solid state chemistry, and drug product development and commercial supply services enable an integrated offering to solve your challenges and move your product to the next milestone.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online